VANCOUVER - Zymeworks Inc . (NASDAQ: NASDAQ:ZYME), a biotechnology firm engaged in developing multifunctional biotherapeutics, has announced the acceleration of its '5 by 5' strategy for solid tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results